SEO URLwww.firestrike.ai/deals/day-one-biopharma-servier-acquisition-2026-1
acquisitionAnnounced · Apr 24, 2026medicalSource · Community DiscussionsArticle · Factual
Servier acquires Day One Biopharma
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$2.5B
Target
Day One Biopharma
NASDAQ: DAWN · Brisbane, California
Acquirer
Servier
Full Acquisition
Status
Pending
Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Pending. Sector: medical. Target headquarters context: Brisbane, California, United States.
This page summarizes publicly available information about the transaction as of 2026-04-24. Figures and status may change as filings and press coverage update.
Servier Announces the Completion of the Acquisition of Day One Biopharmaceuticals Servier shared a post on LinkedIn
Deal timeline
Announced
Apr 24, 2026 · oncodaily.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in medical with a reported deal value of $2.5B. Figures and status may change as sources update.
Sources: oncodaily.com · Primary article · FireStrike proprietary index